Hepatitis can damage your liver for years without symptoms. Learn how these viruses spread—and what truly protects your liver ...

The Department of Health and Human Services (HHS) is reorganizing and cutting 10,000 members, with delayed announcements ...

In a morgue on Gravier Street in New Orleans, bodies stored in freezers at LSU Health Sciences Center have a big job ahead of ...

“Will you reassure mothers unequivocally and without qualification that the measles and the hepatitis B vaccines do not cause autism ... audiences), this question is best asked to the high-profile ...

E mployees of the U.S. Department of Health and Human Services (HHS) knew that mass layoffs would be coming on April 1. But ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase III MUSETTE trial comparing a high dose of Ocrevus® (ocrelizumab) intravenous (IV) infusion to the ...

The government continues to provide medical care to foreign nationals detained following their arrest in scam operations in ...

Paul M. Renfro provides a rich history of Ryan White’s AIDS diagnosis, his legal battle for the right to attend public school, his celebrity status as an “innocent victim” of the HIV/AIDS epidemic, ...

Desai’s family members rarely missed a moment of the high-profile trial ... nights wondering if they were infected with the hepatitis C virus when all the notices went out.

Gilead Sciences Inc. CEO Daniel O'Day's compensation rose 4.8% last year to $23.7 million — roughly $97 for every buck made ...

AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

AstraZeneca's IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...